Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery
研究了制药企业如何通过内部基础研究和鼓励发表论文来吸收公共基础研究成果，并发现企业与科学界的合著联系越强，其内部组织和药物发现绩效越好。
We examine the interface between for‐profit and publicly funded research in pharmaceuticals. Firms access upstream basic research through investments in absorptive capacity in the form of in‐house basic research and ‘pro‐publication’ internal incentives. Some firms also maintain extensive connections to the wider scientific community, which we measure using data on coauthorship of scientific papers between pharmaceutical company scientists and publicly funded researchers. ‘Connectedness’ is significantly correlated with firms’ internal organization, as well as their performance in drug discovery. The estimated impact of ‘connectedness’ on private research productivity implies a substantial return to public investments in basic research.